Alexion Pharmaceuticals, Inc. ALXN

Alexion Pharmaceuticals, Inc. DPO Ratio 2011-2026 | ALXN

Annual DPO Ratio Alexion Pharmaceuticals, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
78.2	68.5	72.6	56.9	90.5	89.8	92.4	44.4	108	62.8

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
108	44.4	76.4

DPO Ratio of other stocks in the Biotechnology industry

	Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
	AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
	I-Mab IMAB	2.24 K	-	-	$ 866 M	China
	Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
	Enlivex Therapeutics Ltd. ENLV	193	$ 0.77	-4.12 %	$ 35.2 M	Israel
	Exelixis EXEL	148	$ 48.16	4.22 %	$ 13.1 B	USA
	Fortress Biotech FBIO	400	$ 2.39	-0.42 %	$ 66.7 M	USA
	Compugen Ltd. CGEN	82.7	$ 2.9	1.4 %	$ 271 M	Israel
	Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
	ACADIA Pharmaceuticals ACAD	75.2	$ 22.4	-0.71 %	$ 3.71 B	USA
	Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
	Esperion Therapeutics ESPR	7.93 K	$ 3.14	-	$ 653 M	USA
	Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
	Gilead Sciences GILD	45.3	$ 131.33	-2.04 %	$ 163 B	USA
	AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
	Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
	Arcutis Biotherapeutics ARQT	133	$ 21.17	2.47 %	$ 2.69 B	USA
	Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
	Autolus Therapeutics plc AUTL	9.57	$ 1.57	-2.48 %	$ 418 M	Britain